FAKTOR-OPTIONSSCHEIN - HALEON Stock

Certificat

DE000MG1K2V5

Market Closed - Börse Stuttgart 07:05:09 2024-06-05 EDT
10.19 EUR +0.30% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month-2.67%
1 month+3.66%
Date Price Change
24-06-05 10.19 +0.30%
24-06-04 10.16 -2.40%
24-06-03 10.41 -0.57%
24-05-31 10.47 +0.19%
24-05-30 10.45 -3.42%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 07:05 am

More quotes

Static data

Product typeProductos Exóticos
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG1K2V
ISINDE000MG1K2V5
Date issued 2024-04-03
Strike 403.4 p
Maturity Unlimited
Parity 0.09 : 1
Emission price 10
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 11.59
Lowest since issue 8.99
Spread 0.04
Spread %0.40%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.278 GBP
Average target price
3.646 GBP
Spread / Average Target
+11.24%
Consensus